Propanc Biopharma executes 1-for-10 reverse stock split on Nasdaq

October 22, 2026 8:30 AM EDT Send to a Friend
Propanc Biopharma, Inc. (NASDAQ: PPCB), a biopharmaceutical company based in Melbourne, Australia, announced that its board of directors approved a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login